𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo

✍ Scribed by Tao Wang; Wei Huang; Fei Chen

Book ID
116719318
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
516 KB
Volume
82
Category
Article
ISSN
0024-3205

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Troglitazone inhibits tumor growth in he
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo
✍ Jun Yu; Liang Qiao; Lars Zimmermann; Matthias P. A. Ebert; Hongxia Zhang; Wendy πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 513 KB

Peroxisome proliferator-activated receptor gamma (PPARgamma) has been implicated in the differentiation and growth inhibition of cancer cells. We examined the effects of PPARgamma activation by troglitazone on hepatocellular carcinoma (HCC) cell growth, proliferation, and apoptosis in vitro and in v

Soluble glypican 3 inhibits the growth o
Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo
✍ Sandra I. Zittermann; Mariana I. Capurro; Wen Shi; Jorge Filmus πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 695 KB

## Abstract The heterogeneity of the molecular pathology of HCC poses a formidable obstacle to the development of non‐cytotoxic therapies. Several pro‐tumorigenic signaling pathways can be aberrantly activated in HCC, including those triggered by Wnts. Glypican‐3 (GPC3), a membrane‐bound heparan su